Short interest for Boston Beer Co gives investors a sense of the degree to which investors are betting on the decline of Boston Beer Co's stock. Short interest data is updated every two weeks.

Boston Beer Co Stock (NYSE:SAM), Short Interest Report

Boston Beer Co

Boston Beer is a top player in high-end malt beverages and adjacent categories in the us, with strong positions in craft beer, flavored malt beverages, hard cider, and hard seltzer. The bulk of volume and revenue is concentrated in four brands: Samuel Adams, Angry Orchard, Twisted Tea, and Truly. Beverages are produced using a hybrid model leveraging both in-house capacities and third-party breweries through contract arrangements. While the firm is required to use distributors to reach end markets, including retailers and on-premises operators, it also employs 500 internal sales representatives to educate the market about its products. The firm generates over 95% of sales in the us.

Boston,,Massachusetts,-,May,25,,2018:,The,Samuel,Adams,Statue

Cannabis

TLRY

Sam Adams maker Boston Beer Company isn&#39;t seeing its cannabis-infused beverage segment drain revenue from its flagship lager.

Sam Adams Says Hold My Beer — And You Are: Sales Numbers Dispute Cannabis Cannibalization Narrative

Molson Coors Blue Moon beer

Analyst Color

Equities

News

Upgrades

Price Target

Reiteration

Analyst Ratings

Trading Ideas

General

Goldman Sachs analyst Bonnie Herzog is incrementally more positive on Molson Coors Beverage &amp; Constellation Brands but incrementally negative on Boston Beer Company based on feedback from the beer distributor contacts in the recent Beverage Bytes survey.

Goldman Sachs Is Incrementally More Positive On Molson Coors &amp; Constellation Brands: Here&#39;s Why

Long Ideas

Initiation

With consumer spending taking a hit on elevated interest rates, more economical alcohol brands, especially beer stocks, have been in focus.

Analyst Michael Lavery of Piper Sandler initiated coverage of these three beer brands, highlighting their prospects.

3 Beer Stocks: What This Analyst Thinks Is Brewing

Boston Beer Company, Inc. (The) Common Stock

Boston Beer Co Inc

Silvercrest Asset Management Group Inc. - Common Stock

Silvercrest Asset Management Group Inc

SANDVIK MATLS TECH HLDG by SANDVIK MATLS TECHNOLOGY HLDG AB

Alleima AB

SAMSARA LUGGAGE INC by Samsara Luggage, Inc.

Samsara Luggage Inc

The Advisors' Inner Circle Fund III Strategas Macro Momentum ETF

Sama Resources Inc

Samoyedcoin

The Advisors' Inner Circle Fund III Strategas Macro Thematic Opportunities ETF

Sam Adams maker Boston Beer Co (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SAM#NYSE">SAM</a>) isn&#8217;t seeing its cannabis-infused beverage segment tap revenue <a href="https://www.benzinga.com/topic/beer">from its flagship lager</a>. 
What Happened: The company disclosed its financial results for the first quarter, which ended on March 30. Its performance exceeded analyst expectations, too. 
<ul>
<li>The company reported a net revenue of $426.1 million </li>
<li>That&#8217;s more than 3.1% higher than analyst estimates of $413.21 million.</li>
<li>Earnings per share (EPS) of $1.04 was above the analyst estimate for EPS of 9 cents.</li>
</ul>
Sam Adams likely owes some of its success to the backlash Anheuser-Busch Inbev (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BUD#NYSE">BUD</a>) faced from conservative beer drinkers. The Bud Light parent company <a href="https://www.benzinga.com/news/earnings/24/02/37398043/why-bud-light-parent-ab-inbev-shares-are-taking-a-hit-today">saw sales plummet</a> on the heels of a promotional campaign with transgender influencer Dylan Mulvaney.
THC&#8217;s so-called cannibalization of alcohol doesn&#8217;t seem to resonate at Sam Adams, nor does it track at Tilray Brands Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TLRY#NASDAQ">TLRY</a>). The Florida-based cannabis company, which <a href="https://www.benzinga.com/markets/cannabis/23/10/35031971/tilray-completes-acquisition-of-8-beer-brands-from-bud-light-parent-anheuser-busch">purchased craft beer brands </a>from AB Inbev, <a href="https://news.bloomberglaw.com/cannabis/craft-beer-is-saving-tilray-from-cannabis-vegetable-woes-1">saw</a> alcohol revenue spike 117% to $47 million.
See Also: <a href="https://www.benzinga.com/analyst-ratings/analyst-color/24/03/37893077/3-beer-stocks-what-this-analyst-thinks-is-brewing">3 Beer Stocks — What This Analyst Thinks Is Brewing</a>
Why It Matters: Even before Boston Beer first <a href="https://www.bostonbeer.com/news/2021/05/the-boston-beer-company-to-begin-research-and-development-of-non-alcoholic-cannabis-beverages" target="_blank" rel="noreferrer noopener">entered</a> the cannabis beverage market, industry analysts (i.e., Deloitte) <a href="https://www2.deloitte.com/content/dam/Deloitte/ca/Documents/c-and-ip/ca-en-consumer-nurturing-new-growth-en-aoda-may31.pdf">predicted</a> that alcohol and tobacco companies would utilize M&amp;A or establish new product segments &#8220;to avoid losing market share to competing cannabis products.&#8221;
But, as it turns out, Boston Beer&#8217;s customers are still enjoying Sam Adams in addition to new THC-infused items <a href="https://www.benzinga.com/markets/cannabis/22/05/27344695/the-boston-beer-company-introduces-teapot-a-new-line-of-cannabis-infused-iced-teas" target="_blank" rel="noreferrer noopener">such as</a> Teapot.
Teapot, the 40-year-old company boasts, is Canada&#8217;s premier cannabis tea brand. The company did not disclose THC beverage sales numbers in its most recent financial <a href="https://investors.bostonbeer.com/news-releases/news-release-details/boston-beer-reports-first-quarter-financial-results-1">report</a>. 
"We saw a unique opportunity as consumer relationships with alcohol evolve, especially in a post-COVID world, where cannabis acceptance is on the rise. This convergence of trends led us to create <a href="https://www.benzinga.com/topic/cannabis-beverages" target="_blank" rel="noreferrer noopener">cannabis-infused beverages</a>," Paul Weaver, head of cannabis at Boston Beer, told Benzinga last year.
Teapot is not listed among Boston Beer&#8217;s so-called &#8220;core brands&#8221; (Sam Adams, Angry Orchard Hard Cider, Dogfish Head, Truly Hard Seltzer and Twisted Tea). 
Boston Beer also backs Uncle Arnie&#8217;s, a <a href="https://www.benzinga.com/markets/cannabis/23/06/32829540/thc-beverage-uncle-arnies-raises-capital-with-investments-from-samuel-adams-founders">cannabis-infused beverage startup</a>. 
Other beer giants aren&#8217;t bullish on the THC drink segment. Molson Coors Beverages Co. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TAP#NYSE">TAP</a>), for example, exited a cannabis-related joint venture with <a href="https://www.benzinga.com/markets/cannabis/22/11/29784310/molson-coors-says-farewell-to-cannabis-and-its-partnership-with-hexo-heres-why">HEXO Corp. in 2022</a>. 
Now Read: <a href="https://www.benzinga.com/markets/cannabis/23/08/34125331/boston-beer-exec-wants-to-turn-time-tested-liquor-logic-into-cannabis-retail-gold">Boston Beer Exec Wants To Turn Time-Tested Liquor Logic Into Cannabis Retail Gold</a>
Image: Shutterstock

9 analysts have expressed a variety of opinions on Boston Beer Co (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SAM#NYSE">SAM</a>) over the past quarter, offering a diverse set of opinions from bullish to bearish.
The table below provides a concise overview of recent ratings by analysts, offering insights into the changing sentiments over the past 30 days and drawing comparisons with the preceding months for a holistic perspective.
<table>
<thead>
<tr>
<th></th>
<th style="text-align: right;">Bullish</th>
<th style="text-align: right;">Somewhat Bullish</th>
<th style="text-align: right;">Indifferent</th>
<th style="text-align: right;">Somewhat Bearish</th>
<th style="text-align: right;">Bearish</th>
</tr>
</thead>
<tbody>
<tr>
<td>Total Ratings</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">6</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">1</td>
</tr>
<tr>
<td>Last 30D</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td>1M Ago</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">1</td>
</tr>
<tr>
<td>2M Ago</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">4</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td>3M Ago</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
</tbody>
</table>
In the assessment of 12-month price targets, analysts unveil insights for Boston Beer Co, presenting an average target of $321.56, a high estimate of $355.00, and a low estimate of $250.00. This current average represents a 1.66% decrease from the previous average price target of $327.00. 
<img src="https://www.benzinga.com/files/images/story/2024/1714154474_0.png" alt="price target chart" />
<h2>Deciphering Analyst Ratings: An In-Depth Analysis</h2>
The standing of Boston Beer Co among financial experts is revealed through an in-depth exploration of recent analyst actions. The summary below outlines key analysts, their recent evaluations, and adjustments to ratings and price targets.
<table>
<thead>
<tr>
<th>Analyst</th>
<th>Analyst Firm</th>
<th>Action Taken</th>
<th>Rating</th>
<th>Current Price Target</th>
<th>Prior Price Target</th>
</tr>
</thead>
<tbody>
<tr>
<td>Eric Serotta</td>
<td>Evercore ISI Group</td>
<td>Raises</td>
<td>In-Line</td>
<td>$325.00</td>
<td>$310.00</td>
</tr>
<tr>
<td>Filippo Falorni</td>
<td>Citigroup</td>
<td>Lowers</td>
<td>Neutral</td>
<td>$315.00</td>
<td>$350.00</td>
</tr>
<tr>
<td>Bonnie Herzog</td>
<td>Goldman Sachs</td>
<td>Lowers</td>
<td>Sell</td>
<td>$250.00</td>
<td>$257.00</td>
</tr>
<tr>
<td>Michael Lavery</td>
<td>Piper Sandler</td>
<td>Announces</td>
<td>Overweight</td>
<td>$350.00</td>
<td>-</td>
</tr>
<tr>
<td>Nik Modi</td>
<td>RBC Capital</td>
<td>Maintains</td>
<td>Sector Perform</td>
<td>$337.00</td>
<td>-</td>
</tr>
<tr>
<td>Filippo Falorni</td>
<td>Citigroup</td>
<td>Lowers</td>
<td>Neutral</td>
<td>$350.00</td>
<td>$370.00</td>
</tr>
<tr>
<td>Sean King</td>
<td>UBS</td>
<td>Lowers</td>
<td>Neutral</td>
<td>$355.00</td>
<td>$390.00</td>
</tr>
<tr>
<td>Eric Sheridan</td>
<td>Morgan Stanley</td>
<td>Lowers</td>
<td>Underweight</td>
<td>$275.00</td>
<td>$285.00</td>
</tr>
<tr>
<td>Nik Modi</td>
<td>RBC Capital</td>
<td>Maintains</td>
<td>Sector Perform</td>
<td>$337.00</td>
<td>-</td>
</tr>
</tbody>
</table>
<h3>Key Insights:</h3>
<ul>
<li>Action Taken: Responding to changing market dynamics and company performance, analysts update their recommendations. Whether they 'Maintain', 'Raise', or 'Lower' their stance, it signifies their response to recent developments related to Boston Beer Co. This offers insight into analysts' perspectives on the current state of the company.</li>
<li>Rating: Offering insights into predictions, analysts assign qualitative values, from 'Outperform' to 'Underperform'. These ratings convey expectations for the relative performance of Boston Beer Co compared to the broader market.</li>
<li>Price Targets: Analysts predict movements in price targets, offering estimates for Boston Beer Co's future value. Examining the current and prior targets offers insights into analysts' evolving expectations.</li>
</ul>
For valuable insights into Boston Beer Co's market performance, consider these analyst evaluations alongside crucial financial indicators. Stay well-informed and make prudent decisions using our Ratings Table.
<a href="https://www.benzinga.com/quote/SAM/analyst-ratings?utm_source=Benzinga Insights">Stay up to date on Boston Beer Co analyst ratings.</a>
<h2>Discovering Boston Beer Co: A Closer Look</h2>
Boston Beer is a top player in high-end malt beverages and adjacent categories in the us, with strong positions in craft beer, flavored malt beverages, hard cider, and hard seltzer. The bulk of volume and revenue is concentrated in four brands: Samuel Adams, Angry Orchard, Twisted Tea, and Truly. Beverages are produced using a hybrid model leveraging both in-house capacities and third-party breweries through contract arrangements. While the firm is required to use distributors to reach end markets, including retailers and on-premises operators, it also employs 500 internal sales representatives to educate the market about its products. The firm generates over 95% of sales in the us.
<h3>A Deep Dive into Boston Beer Co's Financials</h3>
Market Capitalization Analysis: Falling below industry benchmarks, the company's market capitalization reflects a reduced size compared to peers. This positioning may be influenced by factors such as growth expectations or operational capacity.
Negative Revenue Trend: Examining Boston Beer Co's financials over 3 months reveals challenges. As of 31 December, 2023, the company experienced a decline of approximately -12.02% in revenue growth, reflecting a decrease in top-line earnings. As compared to competitors, the company encountered difficulties, with a growth rate lower than the average among peers in the Consumer Staples sector.
Net Margin: Boston Beer Co's net margin lags behind industry averages, suggesting challenges in maintaining strong profitability. With a net margin of -4.6%, the company may face hurdles in effective cost management.
Return on Equity (ROE): Boston Beer Co's ROE falls below industry averages, indicating challenges in efficiently using equity capital. With an ROE of -1.65%, the company may face hurdles in generating optimal returns for shareholders.
Return on Assets (ROA): Boston Beer Co's ROA lags behind industry averages, suggesting challenges in maximizing returns from its assets. With an ROA of -1.23%, the company may face hurdles in achieving optimal financial performance.
Debt Management: Boston Beer Co's debt-to-equity ratio is below industry norms, indicating a sound financial structure with a ratio of 0.04.
<h2>What Are Analyst Ratings?</h2>
Ratings come from analysts, or specialists within banking and financial systems that report for specific stocks or defined sectors (typically once per quarter for each stock). Analysts usually derive their information from company conference calls and meetings, financial statements, and conversations with important insiders to reach their decisions.
Some analysts also offer predictions for helpful metrics such as earnings, revenue, and growth estimates to provide further guidance as to what to do with certain tickers. It is important to keep in mind that while stock and sector analysts are specialists, they are also human and can only forecast their beliefs to traders.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Cracking The Code: Understanding Analyst Reviews For Boston Beer Co

Evercore ISI Group analyst Eric Serotta maintains Boston Beer Co (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SAM#NYSE">SAM</a>) with a In-Line and raises the price target from $310 to $325.

Evercore ISI Group Maintains In-Line on Boston Beer Co, Raises Price Target to $325

Boston Beer shares are trading higher after the company reported better-than-expected Q1 financial results and issued FY24 GAAP EPS guidance.

WIIM

Guidance

Boston Beer Co Sees FY24 GAAP EPS $7.00-$11.00 Vs $9.91 Est.

Boston Beer Co (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SAM#NYSE">SAM</a>) reported quarterly earnings of $1.04 per share which beat the analyst consensus estimate of $0.08 by 1200 percent. The company reported quarterly sales of $426.100 million which beat the analyst consensus estimate of $413.205 million by 3.12 percent. This is a 3.93 percent increase over sales of $410.000 million the same period last year.

Earnings

Earnings Beats

Boston Beer Co Q1 2024 GAAP EPS $1.04 Beats $0.08 Estimate, Sales $426.100M Beat $413.205M Estimate

Citigroup analyst Filippo Falorni maintains Boston Beer Co (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SAM#NYSE">SAM</a>) with a Neutral and lowers the price target from $350 to $315.

Citigroup Maintains Neutral on Boston Beer Co, Lowers Price Target to $315

Goldman Sachs analyst Bonnie Herzog is incrementally more positive on Molson Coors Beverage Co (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TAP#NYSE">TAP</a>) &amp; Constellation Brands Inc (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/STZ#NYSE">STZ</a>) and incrementally negative on Boston Beer Company Inc (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SAM#NYSE">SAM</a>) based on feedback from the beer distributor contacts in the recent Beverage Bytes survey.
The analyst upgraded the shares of Molson Coors Beverage&nbsp;from&nbsp;<a target="_blank" href="https://www.benzinga.com/quote/TAP/analyst-ratings" rel="noreferrer noopener">Neutral to Buy&nbsp;</a>and raised the price target from $66 to $75.
The analyst sees a positive risk/reward given the distributors expect TAP to be a big winner of spring shelf resets, gaining an incremental mid-single-digit percentage of shelf space on average.
More distributors reported share gains strengthening for Miller Lite &amp; Coors Light with nearly 80% of distributors expecting the brands to be able to hold onto their share gains, notes the analyst.
The analyst notes 78% of distributors had more inventory of TAP brands in March, which suggests TAP may have shipped even more than anticipated in first-quarter ahead of spring resets.
The analyst expects a first-quarter beat for TAP, reflecting an improved outlook on shipment/depletion growth in the Americas.
The analyst expects the stock to re-rate higher as TAP's market share tailwinds prove more sustainable than the market currently appreciates.
The analyst reiterates a&nbsp;<a target="_blank" href="https://www.benzinga.com/quote/STZ/analyst-ratings" rel="noreferrer noopener">Buy rating</a>&nbsp;on the shares of Constellation Brands&nbsp;with a price target of $290, ahead of its fourth-quarter results on April 11.
The analyst sees a potential top &amp; bottom line beat based on positive feedback suggesting STZ's beer volume trends remain robust with the brand poised to be the biggest winner of incremental shelf/cooler space this spring.
The analyst's bullish view is also supported by the long runway of growth ahead for Modelo given strong underlying consumer demand, favorable demographic trends, strong and clear brand positioning.
STZ&#8217;s powerful innovation is expected to drive up to 40% of its volume growth over the next 5 years, up from 30% historically, notes the analyst.
The analyst continues to see enough momentum in STZ's business to deliver attractive growth driven by its core beer brands led by Modelo. STZ remains one of the top stock picks for analyst.
The analyst reiterates a&nbsp;<a target="_blank" href="https://www.benzinga.com/quote/SAM/analyst-ratings" rel="noreferrer noopener">Sell rating</a>&nbsp;on the shares of Boston Beer&nbsp;and lowers the price target from $257 to $250.
According to the analyst, distributors report momentum starting to slow for Twisted Tea in the last few months as new competitors flood the hard tea category.&nbsp;
Despite an upbeat outlook for Twisted Tea, the analyst notes that the risk-reward for SAM still largely skews negative, given uncertainty about whether Twisted will be enough to offset Truly's losses.
The analyst notes that distributors are continuing to trim their inventory of SAM products and expect retailers to allocate less shelf/cooler space during the spring resets.
Hence, the analyst lowers 1Q24/FY24/FY25 EPS estimates by -$0.28/-$0.58/-$0.46 to $0.11/$9.72/$12.63.
The analyst sees a more negative risk/reward for the stock near-term until there are more signs of a sustained topline turnaround story.
Price Action: SAM shares are trading lower by 1.01% at $293.99 on the last check Tuesday.
Photo via Shutterstock

Goldman Sachs Is Incrementally More Positive On Molson Coors & Constellation Brands: Here's Why

Boston Beer Co (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SAM#NYSE">SAM</a>) underwent analysis by 9 analysts in the last quarter, revealing a spectrum of viewpoints from bullish to bearish.
The table below provides a snapshot of their recent ratings, showcasing how sentiments have evolved over the past 30 days and comparing them to the preceding months.
<table>
<thead>
<tr>
<th></th>
<th style="text-align: right;">Bullish</th>
<th style="text-align: right;">Somewhat Bullish</th>
<th style="text-align: right;">Indifferent</th>
<th style="text-align: right;">Somewhat Bearish</th>
<th style="text-align: right;">Bearish</th>
</tr>
</thead>
<tbody>
<tr>
<td>Total Ratings</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">5</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">1</td>
</tr>
<tr>
<td>Last 30D</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">1</td>
</tr>
<tr>
<td>1M Ago</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td>2M Ago</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">4</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td>3M Ago</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
</tbody>
</table>
Insights from analysts' 12-month price targets are revealed, presenting an average target of $334.56, a high estimate of $422.00, and a low estimate of $250.00. This upward trend is evident, with the current average reflecting a 0.97% increase from the previous average price target of $331.33.
<img src="https://www.benzinga.com/files/images/story/2024/1712667659_0.png" alt="price target chart" />
<h2>Diving into Analyst Ratings: An In-Depth Exploration</h2>
An in-depth analysis of recent analyst actions unveils how financial experts perceive Boston Beer Co. The following summary outlines key analysts, their recent evaluations, and adjustments to ratings and price targets.
<table>
<thead>
<tr>
<th>Analyst</th>
<th>Analyst Firm</th>
<th>Action Taken</th>
<th>Rating</th>
<th>Current Price Target</th>
<th>Prior Price Target</th>
</tr>
</thead>
<tbody>
<tr>
<td>Bonnie Herzog</td>
<td>Goldman Sachs</td>
<td>Lowers</td>
<td>Sell</td>
<td>$250.00</td>
<td>$257.00</td>
</tr>
<tr>
<td>Michael Lavery</td>
<td>Piper Sandler</td>
<td>Announces</td>
<td>Overweight</td>
<td>$350.00</td>
<td>-</td>
</tr>
<tr>
<td>Nik Modi</td>
<td>RBC Capital</td>
<td>Maintains</td>
<td>Sector Perform</td>
<td>$337.00</td>
<td>-</td>
</tr>
<tr>
<td>Filippo Falorni</td>
<td>Citigroup</td>
<td>Lowers</td>
<td>Neutral</td>
<td>$350.00</td>
<td>$370.00</td>
</tr>
<tr>
<td>Sean King</td>
<td>UBS</td>
<td>Lowers</td>
<td>Neutral</td>
<td>$355.00</td>
<td>$390.00</td>
</tr>
<tr>
<td>Eric Sheridan</td>
<td>Morgan Stanley</td>
<td>Lowers</td>
<td>Underweight</td>
<td>$275.00</td>
<td>$285.00</td>
</tr>
<tr>
<td>Nik Modi</td>
<td>RBC Capital</td>
<td>Maintains</td>
<td>Sector Perform</td>
<td>$337.00</td>
<td>-</td>
</tr>
<tr>
<td>Bill Kirk</td>
<td>Roth MKM</td>
<td>Raises</td>
<td>Buy</td>
<td>$422.00</td>
<td>$406.00</td>
</tr>
<tr>
<td>Nadine Sarwat</td>
<td>Bernstein</td>
<td>Raises</td>
<td>Market Perform</td>
<td>$335.00</td>
<td>$280.00</td>
</tr>
</tbody>
</table>
<h3>Key Insights:</h3>
<ul>
<li>Action Taken: Analysts frequently update their recommendations based on evolving market conditions and company performance. Whether they 'Maintain', 'Raise' or 'Lower' their stance, it reflects their reaction to recent developments related to Boston Beer Co. This information provides a snapshot of how analysts perceive the current state of the company.</li>
<li>Rating: Gaining insights, analysts provide qualitative assessments, ranging from 'Outperform' to 'Underperform'. These ratings reflect expectations for the relative performance of Boston Beer Co compared to the broader market.</li>
<li>Price Targets: Gaining insights, analysts provide estimates for the future value of Boston Beer Co's stock. This comparison reveals trends in analysts' expectations over time.</li>
</ul>
To gain a panoramic view of Boston Beer Co's market performance, explore these analyst evaluations alongside essential financial indicators. Stay informed and make judicious decisions using our Ratings Table.
<a href="https://www.benzinga.com/quote/SAM/analyst-ratings?utm_source=Benzinga Insights">Stay up to date on Boston Beer Co analyst ratings.</a>
<h2>Get to Know Boston Beer Co Better</h2>
Boston Beer is a top player in high-end malt beverages and adjacent categories in the US, with strong positions in craft beer, flavored malt beverages, hard cider, and hard seltzer. The bulk of volume and revenue is concentrated in four brands: Samuel Adams, Angry Orchard, Twisted Tea, and Truly. Beverages are produced using a hybrid model leveraging both in-house capacities and third-party breweries through contract arrangements. While the firm is required to use distributors to reach end markets, including retailers and on-premises operators, it also employs 500 internal sales representatives to educate the market about its products. The firm generates over 95% of sales in the US.
<h3>Financial Milestones: Boston Beer Co's Journey</h3>
Market Capitalization: With restricted market capitalization, the company is positioned below industry averages. This reflects a smaller scale relative to peers.
Revenue Growth: Boston Beer Co's revenue growth over a period of 3 months has faced challenges. As of 31 December, 2023, the company experienced a revenue decline of approximately -12.02%. This indicates a decrease in the company's top-line earnings. When compared to others in the Consumer Staples sector, the company faces challenges, achieving a growth rate lower than the average among peers.
Net Margin: Boston Beer Co's net margin is below industry averages, indicating potential challenges in maintaining strong profitability. With a net margin of -4.6%, the company may face hurdles in effective cost management.
Return on Equity (ROE): Boston Beer Co's ROE lags behind industry averages, suggesting challenges in maximizing returns on equity capital. With an ROE of -1.65%, the company may face hurdles in achieving optimal financial performance.
Return on Assets (ROA): The company's ROA is below industry benchmarks, signaling potential difficulties in efficiently utilizing assets. With an ROA of -1.23%, the company may need to address challenges in generating satisfactory returns from its assets.
Debt Management: The company maintains a balanced debt approach with a debt-to-equity ratio below industry norms, standing at 0.04.
<h2>Analyst Ratings: What Are They?</h2>
Analysts are specialists within banking and financial systems that typically report for specific stocks or within defined sectors. These people research company financial statements, sit in conference calls and meetings, and speak with relevant insiders to determine what are known as analyst ratings for stocks. Typically, analysts will rate each stock once a quarter. 
Some analysts also offer predictions for helpful metrics such as earnings, revenue, and growth estimates to provide further guidance as to what to do with certain tickers. It is important to keep in mind that while stock and sector analysts are specialists, they are also human and can only forecast their beliefs to traders.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

A Closer Look at 9 Analyst Recommendations For Boston Beer Co

Goldman Sachs analyst Bonnie Herzog maintains Boston Beer Co (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SAM#NYSE">SAM</a>) with a Sell and lowers the price target from $257 to $250.

Goldman Sachs Maintains Sell on Boston Beer Co, Lowers Price Target to $250

With consumer spending taking a hit on elevated interest rates, more economical alcohol brands, especially <a href="https://www.benzinga.com/money/beer-stocks">beer stocks, have been in focus</a>.
Analyst Michael Lavery of Piper Sandler&nbsp;initiated&nbsp;coverage of these three beer brands, highlighting their prospects.
The Ratings:
<ul>
<li>Molson Coors Beverage Co (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/tap#NYSE">TAP</a>): Neutral, with a price target of $69.</li>
<li>Boston Beer Company Inc (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/sam#NYSE">SAM</a>): Overweight, with a price target of $350.</li>
<li>Constellation Brands, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/stz#NYSE">STZ</a>): Overweight, with a price target of $300.</li>
</ul>
Check out other <a href="https://www.benzinga.com/analyst-stock-ratings">analyst stock ratings.</a>
The Molson Coors Beverage Thesis: The company gained market share in 2023 at the expense of Anheuser-Busch Inbev SA&#39;s (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/bud#NYSE">BUD</a>) Bud Light&nbsp;and &ldquo;we expect an outsized share lift for it through April 2024,&rdquo; Lavery said in the initiation note.
&ldquo;We expect TAP to benefit from mix lifts from premiumization of its portfolio, but upside beyond beer looks smaller,&rdquo; the analyst wrote. &ldquo;Margin expansion looks achievable to us, but its ongoing strike adds near-term disruption costs and some uncertainty,&rdquo; he added.
The Boston Beer Company Thesis: Twisted Tea and Hard Dew are expected to drive top-line growth, while Hard Mtn Dew could lend &ldquo;significant upside vs. our estimates (and consensus), based on its initial traction in limited distribution,&rdquo; Lavery said.
&ldquo;Smaller launches like Truly Unruly and Sun Cruiser can add to growth, too,&rdquo; the analyst stated. He expressed optimism around continued gross margin expansion driving robust earnings growth.
The Constellation Brands Thesis: The company is poised to benefit from &ldquo;long-term, sustainable U.S. market share tailwinds, as Mexican imports, and its strong brands in particular, have been gaining share for many years,&rdquo; Lavery wrote in the note.
Constellation Brands invested around $550 million in R&amp;D over the last five years and its &ldquo;innovation tailwinds&rdquo; could continue, the analyst said.
&ldquo;STZ is targeting 33-35% enterprise operating margins (F23: ~32%) for F25-F28, and we consider this achievable, with likely upside potential, though commodity input cost variations and other factors are medium-term unknowns,&rdquo; he added.
TAM, SAM, STZ Price Action:&nbsp;Molson Coors Beverage shares were up 0.21% at $67.23,&nbsp;Boston Beer Company shares were up 1.32% at $298.47&nbsp;and Constellation Brands were down 0.60% to $267.73&nbsp;at the time of publication on Friday.
Photo: Shutterstock

In the last three months, 8 analysts have published ratings on Boston Beer Co (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SAM#NYSE">SAM</a>), offering a diverse range of perspectives from bullish to bearish.
The table below provides a snapshot of their recent ratings, showcasing how sentiments have evolved over the past 30 days and comparing them to the preceding months.
<table>
<thead>
<tr>
<th></th>
<th style="text-align: right;">Bullish</th>
<th style="text-align: right;">Somewhat Bullish</th>
<th style="text-align: right;">Indifferent</th>
<th style="text-align: right;">Somewhat Bearish</th>
<th style="text-align: right;">Bearish</th>
</tr>
</thead>
<tbody>
<tr>
<td>Total Ratings</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">5</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td>Last 30D</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td>1M Ago</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">4</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td>2M Ago</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td>3M Ago</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
</tbody>
</table>
Analysts' evaluations of 12-month price targets offer additional insights, showcasing an average target of $345.12, with a high estimate of $422.00 and a low estimate of $275.00. A 0.31% drop is evident in the current average compared to the previous average price target of $346.20. 
<img src="https://www.benzinga.com/files/images/story/2024/1711112431_0.png" alt="price target chart" />
<h2>Breaking Down Analyst Ratings: A Detailed Examination</h2>
In examining recent analyst actions, we gain insights into how financial experts perceive Boston Beer Co. The following summary outlines key analysts, their recent evaluations, and adjustments to ratings and price targets.
<table>
<thead>
<tr>
<th>Analyst</th>
<th>Analyst Firm</th>
<th>Action Taken</th>
<th>Rating</th>
<th>Current Price Target</th>
<th>Prior Price Target</th>
</tr>
</thead>
<tbody>
<tr>
<td>Michael Lavery</td>
<td>Piper Sandler</td>
<td>Announces</td>
<td>Overweight</td>
<td>$350.00</td>
<td>-</td>
</tr>
<tr>
<td>Nik Modi</td>
<td>RBC Capital</td>
<td>Maintains</td>
<td>Sector Perform</td>
<td>$337.00</td>
<td>-</td>
</tr>
<tr>
<td>Filippo Falorni</td>
<td>Citigroup</td>
<td>Lowers</td>
<td>Neutral</td>
<td>$350.00</td>
<td>$370.00</td>
</tr>
<tr>
<td>Sean King</td>
<td>UBS</td>
<td>Lowers</td>
<td>Neutral</td>
<td>$355.00</td>
<td>$390.00</td>
</tr>
<tr>
<td>Eric Sheridan</td>
<td>Morgan Stanley</td>
<td>Lowers</td>
<td>Underweight</td>
<td>$275.00</td>
<td>$285.00</td>
</tr>
<tr>
<td>Nik Modi</td>
<td>RBC Capital</td>
<td>Maintains</td>
<td>Sector Perform</td>
<td>$337.00</td>
<td>-</td>
</tr>
<tr>
<td>Bill Kirk</td>
<td>Roth MKM</td>
<td>Raises</td>
<td>Buy</td>
<td>$422.00</td>
<td>$406.00</td>
</tr>
<tr>
<td>Nadine Sarwat</td>
<td>Bernstein</td>
<td>Raises</td>
<td>Market Perform</td>
<td>$335.00</td>
<td>$280.00</td>
</tr>
</tbody>
</table>
<h3>Key Insights:</h3>
<ul>
<li>Action Taken: In response to dynamic market conditions and company performance, analysts update their recommendations. Whether they 'Maintain', 'Raise', or 'Lower' their stance, it signifies their reaction to recent developments related to Boston Beer Co. This insight gives a snapshot of analysts' perspectives on the current state of the company.</li>
<li>Rating: Analyzing trends, analysts offer qualitative evaluations, ranging from 'Outperform' to 'Underperform'. These ratings convey expectations for the relative performance of Boston Beer Co compared to the broader market.</li>
<li>Price Targets: Analysts predict movements in price targets, offering estimates for Boston Beer Co's future value. Examining the current and prior targets offers insights into analysts' evolving expectations.</li>
</ul>
Considering these analyst evaluations in conjunction with other financial indicators can offer a comprehensive understanding of Boston Beer Co's market position. Stay informed and make well-informed decisions with our Ratings Table.
<a href="https://www.benzinga.com/quote/SAM/analyst-ratings?utm_source=Benzinga Insights">Stay up to date on Boston Beer Co analyst ratings.</a>
<h2>All You Need to Know About Boston Beer Co</h2>
Boston Beer is a top player in high-end malt beverages and adjacent categories in the US, with strong positions in craft beer, flavored malt beverages, hard cider, and hard seltzer. The bulk of volume and revenue is concentrated in four brands: Samuel Adams, Angry Orchard, Twisted Tea, and Truly. Beverages are produced using a hybrid model leveraging both in-house capacities and third-party breweries through contract arrangements. While the firm is required to use distributors to reach end markets, including retailers and on-premises operators, it also employs 500 internal sales representatives to educate the market about its products. The firm generates over 95% of sales in the US.
<h3>Boston Beer Co's Financial Performance</h3>
Market Capitalization Perspectives: The company's market capitalization falls below industry averages, signaling a relatively smaller size compared to peers. This positioning may be influenced by factors such as perceived growth potential or operational scale.
Revenue Challenges: Boston Beer Co's revenue growth over 3 months faced difficulties. As of 31 December, 2023, the company experienced a decline of approximately -12.02%. This indicates a decrease in top-line earnings. As compared to its peers, the revenue growth lags behind its industry peers. The company achieved a growth rate lower than the average among peers in Consumer Staples sector.
Net Margin: The company's net margin is below industry benchmarks, signaling potential difficulties in achieving strong profitability. With a net margin of -4.6%, the company may need to address challenges in effective cost control.
Return on Equity (ROE): Boston Beer Co's ROE is below industry standards, pointing towards difficulties in efficiently utilizing equity capital. With an ROE of -1.65%, the company may encounter challenges in delivering satisfactory returns for shareholders.
Return on Assets (ROA): Boston Beer Co's ROA falls below industry averages, indicating challenges in efficiently utilizing assets. With an ROA of -1.23%, the company may face hurdles in generating optimal returns from its assets.
Debt Management: Boston Beer Co's debt-to-equity ratio is below the industry average at 0.04, reflecting a lower dependency on debt financing and a more conservative financial approach.
<h2>The Significance of Analyst Ratings Explained</h2>
Ratings come from analysts, or specialists within banking and financial systems that report for specific stocks or defined sectors (typically once per quarter for each stock). Analysts usually derive their information from company conference calls and meetings, financial statements, and conversations with important insiders to reach their decisions.
In addition to their assessments, some analysts extend their insights by offering predictions for key metrics such as earnings, revenue, and growth estimates. This supplementary information provides further guidance for traders. It is crucial to recognize that, despite their specialization, analysts are human and can only provide forecasts based on their beliefs.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

A Closer Look at 8 Analyst Recommendations For Boston Beer Co

Piper Sandler analyst Michael Lavery initiates coverage on Boston Beer Co (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SAM#NYSE">SAM</a>) with a Overweight rating and announces Price Target of $350.

Piper Sandler Initiates Coverage On Boston Beer Co with Overweight Rating, Announces Price Target of $350

The most oversold stocks in the consumer staples sector presents an opportunity to buy into undervalued companies.
The RSI is a momentum indicator, which compares a stock&#39;s strength on days when prices go up to its strength on days when prices go down. When compared to a stock&#39;s price action, it can give traders a better sense of how a stock may perform in the short term. An asset is typically considered oversold when the <a href="https://www.benzinga.com/topic/rsi"> RSI is below 30</a>, according to <a href="https://pro.benzinga.com/"> Benzinga Pro</a>.
Here&rsquo;s the latest list of major oversold players in this sector, having an RSI near or below 30.
<h3>HF Foods Group Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/hffg#NASDAQ">HFFG</a>)</h3>
<ul>
<li>On March 14, HF Foods Group posted a profit for the fourth quarter. &ldquo;We are excited by the progress we have made on our operational transformation plan that we expect to help us drive long-term growth and profitability,&rdquo; said Peter Zhang, Chief Executive Officer of HF Foods. The company&rsquo;s stock fell around 10% over the past five days and has a <a href="https://www.benzinga.com/quote/HFFG">52-week low of $3.33</a>.</li>
<li>RSI Value: 22.82</li>
<li>HFFG Price Action: Shares of HF Foods fell 1.2% to close at $3.36 on Thursday.</li>
</ul>
<h3>The Boston Beer Company, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/sam#NYSE">SAM</a>)</h3>
<ul>
<li>On Feb. 27, Boston Beer reported worse-than-expected fourth-quarter financial results. Boston Beer disclosed the retirement of Dave Burwick from the post of President and Chief Executive Officer and member of the Board of Directors, effective April 1, 2024. The company&rsquo;s stock fell around 17% over the past month. It <a href="https://www.benzinga.com/quote/SAM"> has a 52-week low </a> of $293.36.</li>
<li>RSI Value: 26.44</li>
<li>SAM Price Action: Shares of Boston Beer fell 1.4% to close at $294.27 on Thursday.</li>
</ul>
<h3>Inter Parfums, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/ipar#NASDAQ">IPAR</a>)</h3>
<ul>
<li>On Feb. 27, Inter Parfums posted better-than-expected quarterly sales. Jean Madar, Chairman &amp; Chief Executive Officer of Inter Parfums said, &quot;Ongoing demand for our brands, strong holiday season sell-through, and a dynamic fragrance market resulted in a strong 2023 fourth quarter and record full year net sales and earnings results.&quot; The company&rsquo;s stock fell around 11% over the past month and has a 52-week <a href="https://www.benzinga.com/quote/IPAR"> low of $120.71.</a></li>
<li>RSI Value: 29.00</li>
<li>IPAR Price Action: Shares of Inter Parfums fell 1.6% to close at $134.02 on Thursday.</li>
</ul>
<h3>Dollar Tree, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/dltr#NASDAQ">DLTR</a>)</h3>
<ul>
<li>On March 13, Dollar Tree reported worse-than-expected fourth-quarter financial results and issued first-quarter EPS guidance below estimates. &ldquo;Our core operating performance was strong in the fourth quarter, despite some unanticipated developments related to general liability claims,&rdquo; said CFO Jeff Davis. The company&rsquo;s shares lost around 16% over the past five days. The company&rsquo;s 52-week low is $102.77.</li>
<li>RSI Value: 25.45</li>
<li>DLTR Price Action: Shares of Dollar Tree fell 2.5% to close at $125.23 on Wednesday.</li>
</ul>
<h3>United Natural Foods, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/unfi#NYSE">UNFI</a>)</h3>
<ul>
<li>On March 6, United Natural reported second-quarter adjusted earnings per share of 7 cents, beating the analyst consensus of a loss of 1 cent. &ldquo;We are making steady progress on the multiple work-streams underlying both our near-term and longer-term transformation into a more efficient and effective partner to our customers, while we also enhance profitability and long-term shareholder value creation,&rdquo; said Sandy Douglas, UNFI&rsquo;s Chief Executive Officer. The company&rsquo;s shares fell around 29% over the past month. The company <a href="https://www.benzinga.com/quote/UNFI"> has a 52-week low </a> of $11.38.</li>
<li>RSI Value: 23.36</li>
<li>UNFI Price Action: Shares of United Natural Foods fell 4.2% to close at $11.62 on Thursday.</li>
</ul>
&nbsp;
Read More: <a href="https://www.benzinga.com/trading-ideas/long-ideas/24/03/37699845/nerdy-and-3-other-stocks-under-3-insiders-are-buying"> Nerdy And 3 Other Stocks Under $3 Insiders Are Buying </a>

Penny Stocks

Small Cap

Pre-Market Outlook

Markets

DLTR

HFFG

IPAR

UNFI

Top 5 Defensive Stocks That Are Set To Fly This Month

The most oversold stocks in the consumer staples sector presents an opportunity to buy into undervalued companies.
The RSI is a momentum indicator, which compares a stock&#39;s strength on days when prices go up to its strength on days when prices go down. When compared to a stock&#39;s price action, it can give traders a better sense of how a stock may perform in the short term. An asset is typically considered oversold when the <a href="https://www.benzinga.com/topic/rsi"> RSI is below 30</a>, according to <a href="https://pro.benzinga.com/"> Benzinga Pro</a>.
Here&rsquo;s the latest list of major oversold players in this sector, having an RSI near or below 30.
<h3>Seaboard Corporation (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/seb#NYSE">SEB</a>)</h3>
<ul>
<li>On Feb. 13, Seaboard filed its Annual Report on Form 10-K with the United States Securities and Exchange Commission. The company&rsquo;s stock fell around 11% over the past month and has a <a href="https://www.benzinga.com/quote/SEB">52-week low of $3,145.02 </a>.</li>
<li>RSI Value: 28.09</li>
<li>SEB Price Action: Shares of Seaboard fell 0.2% to close at $3,158.00 on Tuesday.</li>
</ul>
<h3>The Boston Beer Company, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/sam#NYSE">SAM</a>)</h3>
<ul>
<li>On Feb. 27, Boston Beer Company reported worse-than-expected fourth-quarter financial results. Boston Beer disclosed the retirement of Dave Burwick from the post of President and Chief Executive Officer and member of the Board of Directors, effective April 1, 2024. The company&rsquo;s stock fell around 9% over the past five days. It <a href="https://www.benzinga.com/quote/SAM"> has a 52-week low </a> of $109.01.</li>
<li>RSI Value: 28.14</li>
<li>SAM Price Action: Shares of Boston Beer fell 0.9% to close at $297.05 on Tuesday.</li>
</ul>
<h3>Universal Corporation (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/uvv#NYSE">UVV</a>)</h3>
<ul>
<li>On Feb. 7, Universal posted an increase in EPS for the third quarter. George C. Freeman, III, Chairman, President, and Chief Executive Officer of Universal, stated, &quot;Universal Corporation again delivered strong financial and operational performance in the third quarter of fiscal year 2024. Operating income and net income for the quarter were up 13% and 28%, respectively, relative to the third quarter of fiscal year 2023, which helped increase operating income and net income for the nine months of fiscal year 2024 by 20% and 13%, respectively, compared to the same period last fiscal year.&quot; The company&rsquo;s stock fell around 16% over the past month and has a 52-week <a href="https://www.benzinga.com/quote/UVV"> low of $44.40.</a></li>
<li>RSI Value: 28.42</li>
<li>UVV Price Action: Shares of Universal gained 1.4% to close at $48.66 on Tuesday.</li>
</ul>
&nbsp;
Read More: <a href="https://www.benzinga.com/news/earnings/24/03/37502521/fear-greed-index-moves-to-greed-zone-dow-dips-over-400-points"> Fear &amp; Greed Index Moves To &#39;Greed&#39; Zone; Dow Dips Over 400 Points</a>

Top 3 Defensive Stocks That May Explode This Month

Boston Beer Co (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SAM#NYSE">SAM</a>) has been analyzed by 7 analysts in the last three months, revealing a diverse range of perspectives from bullish to bearish.
The table below summarizes their recent ratings, showcasing the evolving sentiments within the past 30 days and comparing them to the preceding months.
<table>
<thead>
<tr>
<th></th>
<th style="text-align: right;">Bullish</th>
<th style="text-align: right;">Somewhat Bullish</th>
<th style="text-align: right;">Indifferent</th>
<th style="text-align: right;">Somewhat Bearish</th>
<th style="text-align: right;">Bearish</th>
</tr>
</thead>
<tbody>
<tr>
<td>Total Ratings</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">5</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td>Last 30D</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td>1M Ago</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">3</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td>2M Ago</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td>3M Ago</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
</tbody>
</table>
Analysts' evaluations of 12-month price targets offer additional insights, showcasing an average target of $344.43, with a high estimate of $422.00 and a low estimate of $275.00. A decline of 0.51% from the prior average price target is evident in the current average. 
<img src="https://www.benzinga.com/files/images/story/2024/1709233307_0.png" alt="price target chart" />
<h2>Analyzing Analyst Ratings: A Detailed Breakdown</h2>
A comprehensive examination of how financial experts perceive Boston Beer Co is derived from recent analyst actions. The following is a detailed summary of key analysts, their recent evaluations, and adjustments to ratings and price targets.
<table>
<thead>
<tr>
<th>Analyst</th>
<th>Analyst Firm</th>
<th>Action Taken</th>
<th>Rating</th>
<th>Current Price Target</th>
<th>Prior Price Target</th>
</tr>
</thead>
<tbody>
<tr>
<td>Nik Modi</td>
<td>RBC Capital</td>
<td>Maintains</td>
<td>Sector Perform</td>
<td>$337.00</td>
<td>-</td>
</tr>
<tr>
<td>Filippo Falorni</td>
<td>Citigroup</td>
<td>Lowers</td>
<td>Neutral</td>
<td>$350.00</td>
<td>$370.00</td>
</tr>
<tr>
<td>Sean King</td>
<td>UBS</td>
<td>Lowers</td>
<td>Neutral</td>
<td>$355.00</td>
<td>$390.00</td>
</tr>
<tr>
<td>Eric Sheridan</td>
<td>Morgan Stanley</td>
<td>Lowers</td>
<td>Underweight</td>
<td>$275.00</td>
<td>$285.00</td>
</tr>
<tr>
<td>Nik Modi</td>
<td>RBC Capital</td>
<td>Maintains</td>
<td>Sector Perform</td>
<td>$337.00</td>
<td>-</td>
</tr>
<tr>
<td>Bill Kirk</td>
<td>Roth MKM</td>
<td>Raises</td>
<td>Buy</td>
<td>$422.00</td>
<td>$406.00</td>
</tr>
<tr>
<td>Nadine Sarwat</td>
<td>Bernstein</td>
<td>Raises</td>
<td>Market Perform</td>
<td>$335.00</td>
<td>$280.00</td>
</tr>
</tbody>
</table>
<h3>Key Insights:</h3>
<ul>
<li>Action Taken: Responding to changing market dynamics and company performance, analysts update their recommendations. Whether they 'Maintain', 'Raise', or 'Lower' their stance, it signifies their response to recent developments related to Boston Beer Co. This offers insight into analysts' perspectives on the current state of the company.</li>
<li>Rating: Offering a comprehensive view, analysts assess stocks qualitatively, spanning from 'Outperform' to 'Underperform'. These ratings convey expectations for the relative performance of Boston Beer Co compared to the broader market.</li>
<li>Price Targets: Gaining insights, analysts provide estimates for the future value of Boston Beer Co's stock. This comparison reveals trends in analysts' expectations over time.</li>
</ul>
Analyzing these analyst evaluations alongside relevant financial metrics can provide a comprehensive view of Boston Beer Co's market position. Stay informed and make data-driven decisions with the assistance of our Ratings Table.
<a href="https://www.benzinga.com/quote/SAM/analyst-ratings?utm_source=Benzinga Insights">Stay up to date on Boston Beer Co analyst ratings.</a>
<h2>Delving into Boston Beer Co's Background</h2>
Boston Beer is a top player in high-end malt beverages and adjacent categories in the U.S., with strong positions in craft beer, flavored malt beverage, hard cider, and hard seltzer. The bulk of volume and revenue is concentrated in four brands, including Samuel Adams, Angry Orchard, Twisted Tea, and Truly Hard Seltzer. Beverages are produced using a hybrid model leveraging both in-house capacities and third-party breweries through contract arrangements. While the firm is required to use distributors to reach end markets including retailers and on-premises operators, it also employs 500 internal sales representatives to educate the market about its products. The firm generates over 95% of sales in the U.S.
<h3>Financial Milestones: Boston Beer Co's Journey</h3>
Market Capitalization Analysis: Falling below industry benchmarks, the company's market capitalization reflects a reduced size compared to peers. This positioning may be influenced by factors such as growth expectations or operational capacity.
Positive Revenue Trend: Examining Boston Beer Co's financials over 3 months reveals a positive narrative. The company achieved a noteworthy revenue growth rate of 0.86% as of 30 September, 2023, showcasing a substantial increase in top-line earnings. As compared to competitors, the company encountered difficulties, with a growth rate lower than the average among peers in the Consumer Staples sector.
Net Margin: Boston Beer Co's net margin falls below industry averages, indicating challenges in achieving strong profitability. With a net margin of 7.53%, the company may face hurdles in effective cost management.
Return on Equity (ROE): Boston Beer Co's ROE excels beyond industry benchmarks, reaching 4.1%. This signifies robust financial management and efficient use of shareholder equity capital.
Return on Assets (ROA): The company's ROA is a standout performer, exceeding industry averages. With an impressive ROA of 3.01%, the company showcases effective utilization of assets.
Debt Management: Boston Beer Co's debt-to-equity ratio is below industry norms, indicating a sound financial structure with a ratio of 0.04.
<h2>Analyst Ratings: What Are They?</h2>
Analysts are specialists within banking and financial systems that typically report for specific stocks or within defined sectors. These people research company financial statements, sit in conference calls and meetings, and speak with relevant insiders to determine what are known as analyst ratings for stocks. Typically, analysts will rate each stock once a quarter. 
Analysts may enhance their evaluations by incorporating forecasts for metrics like growth estimates, earnings, and revenue, delivering additional guidance to investors. It is vital to acknowledge that, although experts in stocks and sectors, analysts are human and express their opinions when providing insights.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Evaluating Boston Beer Co: Insights From 7 Financial Analysts

RBC Capital analyst Nik Modi reiterates Boston Beer Co (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SAM#NYSE">SAM</a>) with a Sector Perform and maintains $337 price target.

RBC Capital Reiterates Sector Perform on Boston Beer Co, Maintains $337 Price Target

Stocks dipped modestly following a report indicating a marginal downward revision in the U.S. economic growth rate for the last <a href="https://www.benzinga.com/economics/macro-economic-events/24/02/37362689/us-gdp-growth-downwardly-revised-to-3-2-in-q4-mortgage-demand-tumbles-further-wed">quarter of the year.</a>
This slowdown was attributed to a revision in inventory figures, despite evidence of robust household spending and investment. 
The announcement precedes the release of the Federal Reserve&#8217;s preferred inflation measure, <a href="https://www.benzinga.com/economics/macro-economic-events/24/02/37368845/could-the-feds-preferred-inflation-gauge-signal-an-end-to-the-market-bull-run">expected on Thursday morning. </a>
Despite a generally downward trend on Wednesday, with all major equity indices in the red, the real estate sector emerged as a notable exception, outperforming other sectors.
UnitedHealth Group Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/UNH#NYSE">UNH</a>) was the major laggard among mega-cap stocks, dipping over 4%, after the Department of Justice initiated an antitrust investigation on the <a href="https://www.benzinga.com/markets/equities/24/02/37348735/justice-department-investigates-unitedhealth-group-for-antitrust-violations-report">America's largest health insurer. </a>
Meanwhile, both the U.S. dollar and Treasury yields remained relatively stable.
Bitcoin (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/btc/usd">BTC</a>) stood out as the market&#8217;s brightest spot, gaining over 7% for the day to break above $61,000 amid strong ETF inflows. This surge brings the leading cryptocurrency within just 12 percentage points of its all-time high from 2021.
<h2 class="wp-block-heading">Monday's Performance In Major Indices, ETFs</h2>
<figure class="wp-block-table is-style-stripes"> 
<table>
<tbody>
<tr>
<td>Major Indices</td>
<td>Price</td>
<td>1-day %chg</td>
</tr>
<tr>
<td>S&amp;P 500</td>
<td>5,067.13</td>
<td>-0.2%</td>
</tr>
<tr>
<td>Dow Jones</td>
<td>38,886.64</td>
<td>-0.2%</td>
</tr>
<tr>
<td>Russell 2000</td>
<td>203.25</td>
<td>-0.4%</td>
</tr>
<tr>
<td>Nasdaq 100</td>
<td>17,860.98</td>
<td>-0.6%</td>
</tr>
</tbody>
</table>
</figure>
The SPDR S&amp;P 500 ETF Trust (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SPY#NYSE">SPY</a>) was 0.3% lower to $505.60, the SPDR Dow Jones Industrial Average (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DIA#NYSE">DIA</a>) fell 0.2% to $388.78 and the tech-heavy Invesco QQQ Trust (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/QQQ#NASDAQ">QQQ</a>) fell 0.6% to $434.78, according to <a href="https://pro.benzinga.com/dashboard">Benzinga Pro data</a>. 
The Real Estate Select Sector SPDR Fund (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/XLU#NYSE">XLU</a>), was the notable outperformer, up by 1.3%, while the Health Care Select Sector SPDR Fund (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/XLE#NYSE">XLE</a>) lagged behind, down 0.9%. 
<h2 class="wp-block-heading">Wednesday&#8217;s Stock Movers</h2>
<ul>
<li>Axon Enterprise Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AXON#NASDAQ">AXON</a>) rose 14% as the company reported better-than-expected results last quarter. </li>
<li>Boston Beer Company Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SAM#NYSE">SAM</a>) sank over 18% on disappointing quarterly results. </li>
<li>Other companies reacting to earnings were eBay Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/EBAY#NASDAQ">EBAY</a>), up nearly 8%, Agilent Technologies Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/A#NYSE">A</a>), up 4%, First Solar Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FSLR#NASDAQ">FSLR</a>), up over 2%, Viatris Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/VTRS#NASDAQ">VTRS</a>), down 5%, Icahn Enterprises L.P. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/IEP#NYSE">IEP</a>), up 2%, Advance Auto Parts Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AAP#NYSE">AAP</a>), up 5.5%, Republic Services Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/RSG#NYSE">RSG</a>), down 1%. </li>
<li>Chinese ADRs fell across the board, following Baidu Inc.&#8216;s (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BIDU#NASDAQ">BIDU</a>) disappointing revenue results. Shares of the retail giant fell over 7%. Alibaba Group Holdings Ltd. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BABA#NASDAQ">BABA</a>) fell 3.4%, JD.com Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/JD#NASDAQ">JD</a>) fell 4.4%, and PDD Holdings Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PDD#NASDAQ">PDD</a>) declined 2%. </li>
<li>Companies reporting after the closing bell are Salesforce Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CRM#NASDAQ">CRM</a>), Snowflake Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SNOW#NASDAQ">SNOW</a>), HP Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/HPQ#NYSE">HPQ</a>), Monster Beverage Corp. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MNST#NASDAQ">MNST</a>), Dollar Tree Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/DLTR#NASDAQ">DLTR</a>), Okta Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/OKTA#NASDAQ">OKTA</a>), Paramount Global (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PARA#NASDAQ">PARA</a>) and Nutanix, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NTXT#NASDAQ">NTXT</a>). </li>
</ul>
Read now: <a href="https://www.benzinga.com/economics/macro-economic-events/24/02/37361933/home-prices-set-to-climb-in-2024-will-your-region-emerge-as-winner-or-loser">Home Prices Set To Climb In 2024: Will Your Region Emerge As Winner Or Loser?</a>
Image created using artificial intelligence with Midjourney.

Coverage of Bitcoin, Etherum, Ripple and all the latest digital currencies.

Cryptocurrency

Large Cap

Macro Economic Events

Mid Cap

REIT

Broad U.S. Equity ETFs

Specialty ETFs

New ETFs

Economics

Federal Reserve

Intraday Update

Tech

ETFs

Real Estate

$BTC

AXON

BABA

BIDU

SPDR Dow Jones Industrial Average ETF Trust

EBAY

FSLR

MNST

NTXT

OKTA

PARA

Citigourp Global Markets 2% Protected Notes Linked To The Djia

SNOW

VTRS

Stocks Fall Ahead Of Fed's Inflation Data, UnitedHealth Sinks, Bitcoin Tops $61,000: What's Driving Markets Wednesday?

Shares of Bumble Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/bmbl#NASDAQ">BMBL</a>) fell sharply during Wednesday&rsquo;s session <a href="https://www.benzinga.com/news/earnings/24/02/37349026/bumble-reports-q4-results-eps-miss-revenue-miss-workforce-reductions">following weak quarterly results</a>.
Bumble reported quarterly losses of 19 cents per share which missed the analyst consensus estimate of 12 cents per share. The company reported quarterly sales of $273.64 million which missed the analyst consensus estimate of $275.29 million.
Bumble shares dipped 11.6% to $11.65 on Wednesday.
Here are some other stocks moving in today&#39;s mid-day session.
<h3>Gainers</h3>
<ul>
<li>Vivani Medical, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/vani#NASDAQ">VANI</a>) shares jumped 289% to $3.93 after the company announced preclinical data on weight loss effects for NPM-115 and disclosed that semaglutide is the active pharmaceutical ingredient in NPM-139.</li>
<li>Adial Pharmaceuticals, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/adil#NASDAQ">ADIL</a>) climbed 190% to $2.4598. Adial Pharmaceuticals secured new US patent covering lead product for alcohol use disorder.</li>
<li>vTv Therapeutics Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/vtvt#NASDAQ">VTVT</a>) gained 112% to $17.65 after the company announced a $51 million private placement from healthcare-focused institutional investors and the JDRF T1D Fund.</li>
<li>Bit Brother Limited (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/bets#NASDAQ">BETS</a>) shares rose 63.7% to $4.0750.</li>
<li>Beyond Meat, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/bynd#NASDAQ">BYND</a>) climbed 45% to $10.90 as the company reported stronger-than-expected sales for its fourth quarter.</li>
<li>Incannex Healthcare Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/ixhl#NASDAQ">IXHL</a>) gained 43.6% to $6.06 after the company announced its Psi-GAD1 trial met its primary endpoint.</li>
<li>Bandwidth Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/band#NASDAQ">BAND</a>) surged 43.3% to $17.41 after the company reported better-than-expected fourth quarter financial results and issued FY24 revenue guidance above estimates.</li>
<li>Imunon, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/imnn#NASDAQ">IMNN</a>) climbed 38% to $0.98.</li>
<li>Applied Therapeutics, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/aplt#NASDAQ">APLT</a>) surged 36% to $7.59 after the company announced FDA acceptance and priority review of the NDA for govorestat for the treatment of Classic Galactosemia. The company also announced a $100 million private placement.</li>
<li>Movella Holdings Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/mvla#NASDAQ">MVLA</a>) gained 33.5% to $0.33.</li>
<li>LifeStance Health Group, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/lfst#NASDAQ">LFST</a>) gained 31.5% to $8.81 following strong quarterly sales.</li>
<li>AirNet Technology Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/ante#NASDAQ">ANTE</a>) rose 31.3% to $1.05. AirNet announced changes in senior management team.</li>
<li>Polestar Automotive Holding UK PLC (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/psny#NASDAQ">PSNY</a>) rose 29.9% to $1.9350. Polestar secured $1 billion external funding.</li>
<li>Editas Medicine, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/edit#NASDAQ">EDIT</a>) gained 27.7% to $11.31 after the company reported better-than-expected fourth-quarter financial results.</li>
<li>TG Therapeutics, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/tgtx#NASDAQ">TGTX</a>) jumped 27.2% to $17.69 after the company reported better-than-expected fourth-quarter financial results.</li>
<li>Qurate Retail, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/qrtea#NASDAQ">QRTEA</a>) rose 22% to $1.71 after the company reported fourth-quarter financial results.</li>
<li>B&amp;G Foods, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/bgs#NYSE">BGS</a>) gained 21.4% to $11.41 after the company reported better-than-expected fourth-quarter financial results and issued FY24 revenue guidance.</li>
<li>Flywire Corporation (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/flyw#NASDAQ">FLYW</a>) gained 20% to $29.40 after the company reported better-than-expected fourth quarter financial results.</li>
<li>Flywire Corporation (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/flyw#NASDAQ">FLYW</a>) climbed 17.6% to $28.84 after the company reported better-than-expected fourth quarter financial results.</li>
<li>The Vita Coco Company, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/coco#NASDAQ">COCO</a>) surged 17.3% to $26.32 after the company reported better-than-expected fourth-quarter financial results and issued FY24 net sales guidance.</li>
<li>J-Long Group Limited (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/jl#NASDAQ">JL</a>) gained 17.2% to $18.90.</li>
<li>Revolve Group, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/rvlv#NYSE">RVLV</a>) rose 16% to $20.28 as the company reported upbeat results for its fourth quarter on Tuesday.</li>
<li>Nauticus Robotics, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/kitt#NASDAQ">KITT</a>) gained 15.9% to $0.3549.</li>
<li>Life Time Group Holdings, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/lth#NYSE">LTH</a>) gained 15.3% to $14.32 after the company reported better-than-expected fourth quarter financial results and issued first-quarter revenue guidance above estimates.</li>
<li>Ventyx Biosciences, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/vtyx#NASDAQ">VTYX</a>) shares jumped 15% to $6.96 in pre-market trading following fourth-quarter results.</li>
<li>Connexa Sports Technologies Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/cnxa#NASDAQ">CNXA</a>) shares jumped 14.3% to $0.27.</li>
<li>ACM Research, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/acmr#NASDAQ">ACMR</a>) rose 13.6% to $24.75 in pre-market trading after the company reported better-than-expected fourth-quarter FY23 results.</li>
<li>Vipshop Holdings Limited (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/vips#NYSE">VIPS</a>) gained 12.4% to $19.49 after the company reported better-than-expected fourth quarter financial results.</li>
<li>MicroStrategy Incorporated (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/mstr#NASDAQ">MSTR</a>) climbed 10.9% to $967.01.</li>
<li>Chart Industries, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/gtls#NASDAQ">GTLS</a>) rose 10.5% to $145.33 after the company reported mixed fourth quarter financial results and issued FY24 adjusted EPS guidance above estimates.</li>
<li>Assured Guaranty Ltd. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/ago#NYSE">AGO</a>) gained 9.8% to $94.11 following fourth quarter financial results.</li>
<li>eBay Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/ebay#NASDAQ">EBAY</a>) rose 8.4% to $48.15 after the company reported better-than-expected fourth quarter financial results.</li>
<li>ADT Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/adt#NYSE">ADT</a>) climbed 7.2% to $7.00 following upbeat earnings.</li>
<li>Advance Auto Parts, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/aap#NYSE">AAP</a>) gained 7.1% to $69.32 fourth quarter financial results.</li>
</ul>
<h3>Losers</h3>
<ul>
<li>Oragenics, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/ogen#NYSE">OGEN</a>) shares fell 43.3% to $1.39. Oragenics priced its public offering 1.4 million common shares at $1.50 per share for gross proceeds of $2.1 million.</li>
<li>Integral Ad Science Holding Corp. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/ias#NASDAQ">IAS</a>) fell 40.2% to $1.39 after the company reported fourth-quarter financial results.</li>
<li>Charge Enterprises, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/crge#NASDAQ">CRGE</a>) fell 36.8% to $0.0379.</li>
<li>Palatin Technologies, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/ptn#NYSE">PTN</a>) fell 34.8% to $2.5880 after the company reported results of PL9643 MELODY-1 pivotal Phase 3 clinical trial in patients with dry eye disease.</li>
<li>Inogen, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/ingn#NASDAQ">INGN</a>) dipped 31.2% to $6.43 following weak results.</li>
<li>Eventbrite, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/eb#NYSE">EB</a>) fell 30.2% to $5.81 after the company reported mixed fourth-quarter financial results.</li>
<li>Solarmax Technology Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/smxt#NASDAQ">SMXT</a>) shares fell 27.5% to $5.81. SolarMax Technology announced pricing of initial public offering and listing on Nasdaq.</li>
<li>Novavax, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/nvax#NASDAQ">NVAX</a>) dipped 27% to $4.4000 after the company reported worse-than-expected fourth-quarter sales results and issued first-quarter revenue guidance below estimates.</li>
<li>Lemonade, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/lmnd#NYSE">LMND</a>) shares declined 26.1% to $16.04 after the company reported fourth-quarter financial results.</li>
<li>Vicarious Surgical Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/rbot#NYSE">RBOT</a>) fell 24% to $0.4099 after jumping 57% on Tuesday.</li>
<li>Ocean Biomedical, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/ocea#NASDAQ">OCEA</a>) dipped 21.9% to $1.53.</li>
<li>Infobird Co., Ltd (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/ifbd#NASDAQ">IFBD</a>) fell 21.8% to $1.00.</li>
<li>3D Systems Corporation (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/ddd#NYSE">DDD</a>) fell 21.6% to $4.10 following weak fourth-quarter financial results.</li>
<li>Nerdy, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/nrdy#NYSE">NRDY</a>) fell 21% to $2.4099 following fourth-quarter financial results.</li>
<li>Vertex Energy, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/vtnr#NYSE">VTNR</a>) shares dipped 20.7% to $1.3310 after posting a fourth-quarter loss.</li>
<li>Alignment Healthcare, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/alhc#NASDAQ">ALHC</a>) fell 17.5% to $5.71 after the company reported worse-than-expected fourth-quarter GAAP EPS results.</li>
<li>Progyny, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/pgny#NASDAQ">PGNY</a>) fell 17.2% to $33.79 after the company reported mixed fourth-quarter financial results.</li>
<li>The Boston Beer Company, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/sam#NYSE">SAM</a>) dipped 17.1% to $306.80 after the company reported worse-than-expected fourth-quarter financial results.</li>
<li>Payoneer Global Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/payo#NASDAQ">PAYO</a>) fell 15.6% to $4.69 after the company issued FY24 revenue guidance below estimates.</li>
<li>Concentrix Corporation (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/cnxc#NASDAQ">CNXC</a>) fell 15.3% to $70.25.</li>
<li>Urban Outfitters, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/urbn#NASDAQ">URBN</a>) shares declined 15% to $40.08 after the company reported fourth-quarter financial results.</li>
<li>Hyster-Yale Materials Handling, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/hy#NYSE">HY</a>) fell 14.1% to $60.20 following fourth-quarter results.</li>
<li>The E.W. Scripps Company (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/ssp#NASDAQ">SSP</a>) fell 12.2% to $4.1050 after the company reported mixed fourth-quarter financial results.</li>
<li>Luminar Technologies, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/lazr#NASDAQ">LAZR</a>) dipped 10% to $2.25 following downbeat quarterly results.</li>
<li>Recursion Pharmaceuticals, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/rxrx#NASDAQ">RXRX</a>) shares fell 9.1% to $14.10 after the company reported mixed fourth-quarter financial results.</li>
<li>Baidu, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/bidu#NASDAQ">BIDU</a>) fell 7.1% to $104.42 after the company reported financial Q4 results.</li>
<li>Macy&#39;s, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/m#NYSE">M</a>) fell 4.8% to $18.99.</li>
</ul>
&nbsp;
Now Read This: <a href="https://www.benzinga.com/news/earnings/24/02/37366156/snowflake-gears-up-for-q4-print-these-most-accurate-analysts-revise-forecasts-ahead-of-earnings-cal"> Snowflake Gears Up For Q4 Print; These Most Accurate Analysts Revise Forecasts Ahead Of Earnings Call </a>

Movers

ACMR

ADIL

ALHC

ANTE

APLT

BAND

BETS

BMBL

BYND

CONNEXA SPORTS TECH INC by Connexa Sports Technologies Inc.

CNXA

CNXC

COCO

CRGE

EDIT

FLYW

GTLS

IFBD

IMNN

INGN

IXHL

KITT

LAZR

LFST

LMND

MSTR

MVLA

NRDY

NVAX

OCEA

OGEN

PAYO

PGNY

PSNY

QRTEA

RBOT

RVLV

RXRX

SMXT

TGTX

URBN

VANI

VIPS

VTNR

VTVT

VTYX

Why Bumble Shares Are Trading Lower By 12%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session

Boston Beer GAAP EPS of $1.04 beats by $1.04, revenue of $426.1M beats by $13.8M

The Boston Beer Company, Inc. (SAM) Q1 2024 Earnings Call Transcript

<a href="https://investorplace.com">InvestorPlace - Stock Market News, Stock Advice &amp; Trading Tips</a>
Boston Beer Co (NYSE:<a href="https://investorplace.com/stock-quotes/sam-stock-quote/">SAM</a>) just reported results for the first quarter of 2024.<ul><li>Boston Beer Co reported earnings per share of $1.04. This was above the analyst estimate for EPS of 9 cents.</li><li>The company reported revenue of $426.05 million.</li><li>This was 3.11% better than the analyst estimate for revenue of $413.20 million.</li></ul><div>InvestorPlace Earnings is a project that leverages data from <a href="https://www.tradesmith.com">TradeSmith</a> to automate coverage of quarterly earnings reports. InvestorPlace Earnings distills key takeaways including earnings per share and revenue, as well as how a company stacks up to analyst estimates. These articles are published without human intervention, allowing us to inform our readers of the latest figures as quickly as possible. To report any concerns or inaccuracies, please contact us at <a href="mailto:editor@investorplace.com">editor@investorplace.com</a>.</div><h3>More From InvestorPlace</h3>
		<ul><li>
						<a href="https://investorplace.com/2023/10/no-1-ai-investment-might-be-this-company-youve-never-heard-of/?cid=MKT764787&amp;eid=MKT771245">The #1 AI Investment Might Be This Company You&rsquo;ve Never Heard Of</a>
					</li>
																<li>
						<a href="https://investorplace.com/2023/07/elon-musks-project-omega-stuns-silicon-valley-insiders/?cid=MKT738510&amp;eid=MKT771236">Musk&rsquo;s &ldquo;Project Omega&rdquo; May Be Set to Mint New Millionaires. Here&rsquo;s How to Get In.</a>
					</li>
																<li>
						<a href="https://investorplace.com/2021/01/one-percenter-issues-urgent-warning/?cid=MKT499868&amp;eid=MKT793997">It doesn&rsquo;t matter if you have $500 or $5 million. Do this now.</a>
					</li>
									</ul><div>
			<div></div>
						<div></div>
					</div>
	The post <a href="https://investorplace.com/earning-results/2024/04/sam-stock-earnings-boston-beer-co-for-q1-of-2024/">SAM Stock Earnings: Boston Beer Co Beats EPS, Beats Revenue for Q1 2024</a> appeared first on <a href="https://investorplace.com">InvestorPlace</a>.

SAM Stock Earnings: Boston Beer Co Beats EPS, Beats Revenue for Q1 2024

In a report released yesterday, Bonnie Herzog from Goldman Sachs maintained a Sell rating on Boston Beer (SAM – Research Report), with a price targ...

Sell Rating on Boston Beer Company Amid Sustainability Concerns and One-Off Q1 Benefits

Boston Beer (SAM – Research Report), the Consumer Defensive sector company, was revisited by a Wall Street analyst today. Analyst Eric Serotta from...

Boston Beer Underperforms: Persistent Depletion Rates and Product Line Deceleration Justify Sell Rating

Companies in the Consumer Goods sector have received a lot of coverage today as analysts weigh in on Keurig Dr Pepper (KDP – Research Report) and B...

Analysts' Opinions Are Mixed on These Consumer Goods Stocks: Keurig Dr Pepper (KDP) and Boston Beer (SAM)

There's a lot to be optimistic about in the Consumer Goods sector as 2 analysts just weighed in on Boston Beer (SAM – Research Report) and Altria G...

Analysts' Top Consumer Goods Picks: Boston Beer (SAM), Altria Group (MO)

Boston Beer Stock: Time To Take A Sip (Rating Upgrade)

Ambev S.A.: Diversify Out Of U.S. Assets With Beer Made In Brazil

Warning: SAM is at high risk of performing badly

ABEV

BUDFF

CABGY

CABJF

DGEAF

HEINY

HINKF

NAPA

Press Releases

Samuel Adams Brewing the American Dream® Announces Funkytown Collaboration Brew as Applications Open for the 13th Brewing & Business Experienceship

TWISTED TEA HARD ICED TEA UNVEILS GAME-CHANGING TWIST FOR GOLFERS: CHEATER PANTS

Jim Beam Kentucky Coolers Welcomes Fresh Wave of Flavor with Four New Varieties

TeaPot Releases New 'Good Evening Iced Tea' in Blackberry Rooibos

Restaurants

Dogfish Head Expands Distribution of Spirits-Based RTD Cocktails to Western Canada

The Boston Beer Company Debuts First-of-its-Kind Non-Alc Beverage, General Admission, Available Now via Direct-to-Consumer Shipping

Breathalyzer Market Booms with Technological Advances; Key to Reducing Alcohol-Related Road Deaths

Boston Beer Reports First Quarter Financial Results

SAMUEL ADAMS TAPPED AS THE OFFICIAL BEER AND NON-ALCOHOLIC BEER OF THE PAN-MASS CHALLENGE

Dogfish Head Craft Brewery Unveils New Beer Packaging Artwork & Announces the Return of its Fan-Favorite 120 Minute IPA

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Boston Beer Co Stock (NYSE:SAM), Short Interest Report

People Also Watch